LATEST
Frutas Y Hortalizas Del Sur S.A. Expands Recalls to Include Additional Lots of Great Value Frozen Organic Triple Berry Blend 10 OZ, Great Value Frozen Organic Blueberries 10 OZ and One Lot of Trader Joe’s Frozen Organic Mixed Berry Blend 12 OZ Because of Potential Contamination with Escherichia ColiMultilocal Secures Backing of OAREX to Accelerate Global Growth with New CapitalDea Schedule I Proposal Would Criminalize Compound with Breakthrough Therapy Status for Postpartum DepressionFull-Body Mirrored Adult-Sized Humanoid Robots Fighting in Real-Time for the First TimeCHASING CanFish F2 Heads to Kickstarter, Introducing a New Way to Scout the WaterEurope Turns to Private Enterprise to Close the Gap as BOARD Attracts Support from Over 200 European CEOsStudent Innovators Advance Their Robotic Projects at World Robot Olympiad Entrepreneur Program from Competition to Startup StageAfter Historic FDA Hearing On Psychedelic Therapies, Grassroots Student Group Mobilizes To Shape What Comes NextGaza Anger Breaks Old Political Loyalties in Britain and BeyondChristopher Columbus Identified As A Portuguese Prince In New InvestigationFrutas Y Hortalizas Del Sur S.A. Expands Recalls to Include Additional Lots of Great Value Frozen Organic Triple Berry Blend 10 OZ, Great Value Frozen Organic Blueberries 10 OZ and One Lot of Trader Joe’s Frozen Organic Mixed Berry Blend 12 OZ Because of Potential Contamination with Escherichia ColiMultilocal Secures Backing of OAREX to Accelerate Global Growth with New CapitalDea Schedule I Proposal Would Criminalize Compound with Breakthrough Therapy Status for Postpartum DepressionFull-Body Mirrored Adult-Sized Humanoid Robots Fighting in Real-Time for the First TimeCHASING CanFish F2 Heads to Kickstarter, Introducing a New Way to Scout the WaterEurope Turns to Private Enterprise to Close the Gap as BOARD Attracts Support from Over 200 European CEOsStudent Innovators Advance Their Robotic Projects at World Robot Olympiad Entrepreneur Program from Competition to Startup StageAfter Historic FDA Hearing On Psychedelic Therapies, Grassroots Student Group Mobilizes To Shape What Comes NextGaza Anger Breaks Old Political Loyalties in Britain and BeyondChristopher Columbus Identified As A Portuguese Prince In New Investigation
Europe

Datar Cancer Genetics Partners with The Cancer Screening Trust to Offer Blood-Based Screening

Datar Cancer Genetics has announced its partnership with U.K. based The Cancer Screening Trust to offer its innovative, blood-based, cancer screening Trucheck solution. Datar Cancer Genetics has been at the forefront in developing greater insight into the cancer ecosystem and offering its innovative oncology focussed services to clinicians and patients globally.

  "Our collaboration with The Cancer Screening Trust will allow individuals to avail our cancer screening solutions serviced by our UK lab. Our passion and commitment is to deliver best-in-class, and unparalleled range of blood based diagnostics for clinicians and patients globally", said Dr Vineet Datta, Executive Director, Datar Cancer Genetics. "We are delighted that this partnership will offer our highly accurate cancer detection technology to provide more comprehensive cancer screening. Trucheck is a comprehensive, cancer detection solution  that can  detect over 70 cancers, with a meaningfully unparalleled combination of sensitivity and specificity for early detection of cancers in asymptomatic individuals and localization of the detected cancers to tissue and organ of origin."   “The Cancer Screening Trust is delighted to be in partnership with Datar Cancer Genetics and to be able to offer the Trucheck Intelli blood test to all our clients, as part of our lifetime screening programme. This non-invasive, early detection tool will greatly enhance our Whole Body MRI scan, to offer the best screening package and peace of mind. Datar Cancer Genetics have made significant progress in the liquid biopsy arena and together we will help to diagnose cancer earlier and save lives”  said Frank Hogarty, CEO of The Cancer Screening Trust Ltd.

 

Datar Cancer Genetics is a leading cancer research corporation specializing in non-invasive techniques for better screening, diagnosis, and management of cancer.  Datar Cancer Genetics has a College of American Pathologists (CAP), CLIA, ISO15189, ISO9001 and ISO27001 accredited molecular genomic facility at India with a staff strength over 200, in addition to a state-of-the-art lab facility in the United Kingdom. Our team of scientists, clinicians, advisors and experts, based out of the United Kingdom, U.S.A., Germany and India, help advance our innovative technologies for better cancer management.

 

The Cancer Screening Trust Ltd is a non profit organisation set up to offer a lifetime screening programme to individuals. The company offers an initial consultation, a blood test and a Whole Body MRI scan to gain the fullest picture of a patient’s health, so as to detect any abnormalities at the earliest opportunity. Their aim is to help clients take a proactive stance in their health management and to play a part in the drive to reduce cancer mortality.

 

datarpgx.com

 

thecancerscreeningtrust.co.uk

Related articles

Top